Savita Rangarajan

Publications

87 publications

Page 4 of 9

Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study

Kathelijn Fischer, Roshni Kulkarni, Beatrice Nolan, Johnny Mahlangu, Savita Rangarajan, Giulia Gambino, Lei Diao, Alejandra Ramirez-santiago, Glenn F Pierce & Geoffrey Allen, 2017, The Lancet Haematology, 4(2), e75-e82

DOI: 10.1016/S2352-3026(16)30193-4

Type: article

Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study

V. Jiménez-Yuste, J. Oldenburg, S. Rangarajan, R. Peiró-Jordán & E. Santagostino, 2016, Haemophilia, 22(6), 859-865

DOI: 10.1111/hae.12986

Type: article

Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial

M. Carcao, M. Zak, F. Abdul Karim, H. Hanabusa, S. Kearney, M.-y. Lu, P. Persson, S. Rangarajan & E. Santagostino, 2016, Journal of Thrombosis and Haemostasis, 14(8), 1521-1529

DOI: 10.1111/jth.13360

Type: article

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

P. Collins, E. Chalmers, P. Chowdary, D. Keeling, M. Mathias, J. O'donnell, K. J. Pasi, S. Rangarajan & A. Thomas, 2016, Haemophilia, 22(4), 487-498

DOI: 10.1111/hae.13013

Type: article

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety

T. Lissitchkov, K. Hampton, M. Von Depka, C. Hay, S. Rangarajan, E. Tuddenham, K. Holstein, A. Huth-kühne, I. Pabinger, S. Knaub, J. Bichler & J. Oldenburg, 2016, Haemophilia, 22(2), 225-231

DOI: 10.1111/hae.12793

Type: article

Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors

V. Jiménez-Yuste, J. Oldenburg, S. Rangarajan, M. H Kurth, J. Bozzo & E. Santagostino, 2016, Haemophilia, 22(1), e71-e74

DOI: 10.1111/hae.12857

Type: article

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

B. Nolan, J. Mahlangu, D. Perry, G. Young, R. Liesner, B. Konkle, S. Rangarajan, S. Brown, H. Hanabusa, K. J. Pasi, I. Pabinger, S. Jackson, L. M. Cristiano, X. Li, G. F. Pierce & G. Allen, 2016, Haemophilia, 22(1), 72-80

DOI: 10.1111/hae.12766

Type: article

Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A

Johnny Mahlangu, Margaret Ragni, Naresh Gupta, Savita Rangarajan, Robert Klamroth, Johannes Oldenburg, Keiji Nogami, Guy Young, Lynda Cristiano, Yingwen Dong, Geoffrey Allen, Glenn Pierce & Brian Robinson, 2016, Thrombosis and Haemostasis, 116(07), 1-8

DOI: 10.1160/TH15-10-0780

Type: article

Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A

Paul Batty, Gary W Moore, Sean Platton, James C Maloney, Ben Palmer, Louise Bowles, K John Pasi, Savita Rangarajan & Daniel P Hart, 2015, Thrombosis and Haemostasis, 114(4), 804-811

DOI: 10.1160/TH14-12-1062

Type: article

Inhibitors in nonsevere haemophilia A

Alice S van Velzen, Corien L Eckhardt, Daniel P Hart, Marjolein Peters, Savita Rangarajan, Maria Elisa Mancuso, Frans J Smiers, Kate Khair, Pia Petrini, Victor Jiménez-Yuste, Charles R M Hay, Johanna G van der Bom, Thynn T Yee & Karin Fijnvandraat, 2015, Thrombosis and Haemostasis, 114(1), 46-55

DOI: 10.1160/TH14-11-0940

Type: article

Professor Savita Rangarajan

Connect with Savita

Publications